STAT Plus: With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights
Summit’s lung cancer treatment has wowed researchers. The CEO behind it is a living challenge to the assumptions of many in biotech.
Cancel anytime.
Subscribe nowOur Picks
Our Picks
A stat investigation
A stat investigation